Return to Listing

183 result(s) for Hematologic Cancers

PI Name Protocol # Title
Robert Peterka IRB00000675 Sensorimotor Integration in Human Postural Control
Edward Neuwelt IRB00000922 Phase II Clinical Trial of Patients with High-Grade Glioma Treated with Intra-arterial Carboplatin-based Chemotherapy, Randomized to Treatment with or without Delayed Intravenous Sodium Thiosulfate as a Potential Chemoprotectant against Severe Thrombocytopenia
Edward Neuwelt IRB00001012 A Phase II Study of Patients with Newly Diagnosed Primary Central Nervous System Lymphoma Treated with Methotrexate/BBBD, and Adding Rituximab (an anti CD-20 Antibody) and Carboplatin, to the Treatment Regimen
Christopher Ryan IRB00001666 A Multicenter, Open-Label Single-Arm Study of YONDELIS (trabectedin) for Subjects With Locally Advanced or Metastatic Soft Tissue Sarcoma Who Have Relapsed or Are Refractory to Standard of Care Treatment
Bonnie Nagel IRB00002560 Neurocognition and Brain Development in Youth
Eric Simpson IRB00002568 Pathogenesis of Skin Disease
Edward Neuwelt IRB00002868 Phase I/II Study of Carboplatin, Melphalan and Etoposide Phosphate in Conjunction with Osmotic Opening of the Blood-Brain Barrier and Delayed Intravenous Sodium Thiosulfate Chemoprotection, in Previously Treated Subjects with Anaplastic Oligodendroglioma or Oligoastrocytoma
Vassiliki Tsikitis IRB00003082 Oregon Colorectal Cancer Registry
David Koeller IRB00003120 A Global, Multi-Center, Long-Term, Observational Survey of Patients with Hunter Syndrome (Mucopolysaccharidosis II) - Hunter Outcome Survey (HOS)
Brett Sheppard IRB00003609 Oregon Pancreas Tumor Registry
Ryan Olson IRB00003754 Hazard and Threat Detection
Shoukhrat Mitalipov IRB00003892 [STEM CELLS] Histocompatible human pluripotent cells
Fay Horak IRB00004131 Exercise, Brain Imaging, Cognition, and Gait in Parkinsonism
Tessa Marburger IRB00004753 A Global, Multi-Center, Longitudinal, Observational Survey of Patients with Documented Transthyretin (TTR) Mutations or Wild-Type TTR Amyloidosis.
Andrew Ahmann IRB00005023 TrialNet Natural History Study of the Development of Type 1 Diabetes
Edward Neuwelt IRB00005056 Phase I/II Study of Intra-arterial Melphalan Given with Intra-arterial Carboplatin, Osmotic Blood-Brain Barrier Disruption and Delayed Otoprotective Sodium Thiosulfate for Patients with Recurrent or Progressive CNS Embryonal or Germ Cell Tumors
Kevin Billingsley IRB00005222 Oregon Liver Tumor Registry
Damien Fair IRB00005239 Typical and Atypical Brain Development
Julie Graff IRB00005254 A Phase II Study of CTLA Blockade by Ipilimumab plus Androgen Suppression Therapy in Patients with an Incomplete Response to AST Alone for Metastatic Prostate Cancer
Tomasz Beer IRB00005688 A Phase II study of MAOA inhibitor plus docetaxel in patients receiving and progressing on docetaxel therapy
Kelvin MacDonald IRB00005956 Transepithelial Potential Difference Measurements in Patients with Unusual Variants of Cystic Fibrosis
Lina Reiss IRB00006069 Optimization of Cochlear Implants and Hearing Aids
Jack Kron IRB00006168 Catheter Ablation Versus Anti-arrhythmic Drug Therapy for Atrial Fibrillation (CABANA) Trial
Kathleen Kemmer IRB00006256 I-SPY 2 TRIAL: Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging and Molecular Analysis 2
Joel Nigg IRB00006258 Longitudinal Brain Imaging Study of ADHD
Penelope Hogarth IRB00006459 The Parkinson's Progression Markers Initiative (PPMI)
William Rooney IRB00006509 Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy
Shoukhrat Mitalipov IRB00006709 [STEM CELLS] Mitochondrial gene replacement in human oocytes
Jean-Baptiste Roullet IRB00006790 Sterol and Isoprenoid Research Consortium (STAIR) Smith-Lemli-Opitz Syndrome: A Longitudinal Clinical Study of Patients Receiving Cholesterol Supplementation
Daniel Clayburgh IRB00006918 RTOG 0920: A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
Stephen Spurgeon IRB00007195 A Phase II Proof of Concept Trial to Study Kinase Inhibition in Relapsed/Refractory Acute Leukemias: Using a Comprehensive in Vitro Kinase Inhibitor Panel to Select Individualized Targeted Therapies
Barry Oken IRB00007364 Mindfulness Meditation in Chronic Stress
Christopher Ryan IRB00007404 PVAMC / OHSU: S0931 EVEREST: EVErolimus for Renal Cancer Ensuing Surgical Therapy, A Phase III Study
Gina Vaccaro IRB00007561 C80702: A Phase III Trial of 6 Versus 12 Treatments of Adjuvant FOLFOX Plus Celecoxib or Placebo for Patients With Resected Stage III Colon Cancer
Robert Peterka IRB00007619 Vestibular contribution to the control of human upright stance
Theresa Koppie IRB00007854 PVAMC / OHSU: S1011, A Phase III Surgical Trial to Evaluate the Benefit of a Standard versus an Extended Pelvic Lymphadenectomy Performed at Time of Radical Cystectomy for Muscle Invasive Urothelial Cancer
Christopher Ryan IRB00007943 A Randomized, Double-Blind Phase II, Study of Gemcitabine Alone or in Combination with Pazopanib for Refractory Soft Tissue Sarcoma
Joseph Quinn IRB00008122 Cerebrospinal Fluid Biomarker Discovery
Kathleen Kemmer IRB00008158 PRESENT: Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer with Low to Intermediate HER2 Expression with NeuVax Treatment
Emma Scott IRB00008296 Phase I Infusional Cyclophosphamide and Pulse Dexamethasone With Rapamycin and Hydroxychloroquine in Patients With Relapsed or Refractory Myeloma
Paul Spellman IRB00008314 Personalized Breast Cancer Genomics Registry
Eric Simpson IRB00008446 Skin Barrier Function Assessment in Rare Diseases Caused by Abnormal Sterol and Isoprenoid Metabolism: A Pilot Study
Kerri Winters IRB00008560 Group Exercise Training for Functional Improvement after Treatment: The GET FIT Trial
Akram Khan IRB00008597 A Phase III, International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Event Driven Study to Compare the Time to First Clinical Worsening in Subjects with Pulmonary Arterial Hypertension Receiving UT-15C in Combination with a PDE5-I or ERA Compared with a PDE5-I or ERA Alone
Charles Henrikson IRB00008728 Standard v. Enhanced MRI-Guided Ablation in the Treatment of Ventricular Tachycardia
Jonathan Fellers IRB00008874 PVAMC / OHSU J: Pilot study of the dose response of entacapone on methamphetamine induced interest, mood elevation, and reward
Andy Chen IRB00008906 GO27834: A Randomized, Open-Label, Multicenter, Phase II Trial Evaluating the Safety and Activity of pinatuzumab vedotin (DCDT2980S) in Combination with Rituximab or Polatuzumab Vedotin (DCDS4501A) in Combination with Rituximab and A Non Randomized phase Ib/II Evaluation of Polatuzumab Vedotin in Combination with Obinutuzumab in Patients with Relapsed or Refractory B-cell Cell Non- Hodgkin’s Lymphoma
Sonemany Salinthone IRB00008908 PVAMC / OHSU: Elucidating the Mechanisms that Mediate the Effects of Lipoic Acid in Multiple Sclerosis
Barry Oken IRB00008934 The Cognitive and Physiological Correlates of Novice and Long-Term Meditators
Jeremy Cetnar IRB00008962 A phase 1/2 study combining ipilimumab with abiraterone acetate plus prednisone in chemotherapy- and immunotherapy-naïve patients with progressive metastatic castration-resistant prostate cancer
Fay Horak IRB00008979 Frontal Cortex and Gait Freezing in Parkinson's Disease: Rehabilitation Impact
Charles Thomas IRB00009013 A Study to Determine the Immune Profile of Rectal Adenocarcinoma and its Correlation with the Efficacy of Neoadjuvant Chemoradiotherapy
Andrew Ahmann IRB00009157 Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)
Michael Shapiro IRB00009174 A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome (Odyssey Outcomes)
Kristen Mackiewicz Seghete IRB00009182 Neural Mechanisms of Cognitive Inhibition in Youth with and without a Trauma History
Tomasz Beer IRB00009204 Radiologically Guided Biopsies of Metastatic Castration Resistant Prostate Cancer to Identify Adaptive Mechanisms of Resistance
Christopher Ryan IRB00009241 Randomized, Double-Blind Phase III study of Pazopanib vs Placebo in Patients with Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease Following Metastatectomy
Joshi Alumkal IRB00009259 Identifying Mechanisms of Resistance to Enzalutamide (MDV3100) Treatment in Men with Castration-Resistant Prostate Cancer
Winston Chamberlain IRB00009280 Randomized Clinical Trial of OCT-Guided Laser-Assisted Lemellar Anterior Keratoplasty in Adults for Keratoconus
Winston Chamberlain IRB00009282 Randomized Clinical Trial of OCT-Guided Laser-Assisted Lamellar Anterior Keratoplasty in Adults for Stromal Opacities
Saurabh Gupta IRB00009290 Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional MR (The COAPT Trial)
Deniz Erten-Lyons IRB00009333 A Placebo-controlled, Double-blind, Parallel-group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer’s Disease. BAN2401-G000-201
Julie Graff IRB00009363 PVAMC / OHSU J: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Study of ARN-509 in Men with Non-Metastatic (M0) Castration-Resistant Prostate Cancer
Richard Maziarz IRB00009375 A Phase 1-2 Dose Escalation Study Evaluating Safety and Feasibility of BPX-501 T Cells after Partially Mismatched, Related, T Cell-Depleted HSCT
Gina Vaccaro IRB00009414 A Phase III Study of FOLFIRINOX with or without Hyperacute-Pancreas (Algenpantucel-L) Immunotherapy in Subjects with Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer
Kresimira Milas IRB00009420 Oregon Index of Endocrine Neoplasias (ORION)
Emma Scott IRB00009421 A Phase I Dose-Escalation Study of Carfilzomib in Patients with Previously-Treated Systemic Light-Chain (AL) Amyloidosis
Matthew Taylor IRB00009443 A Randomized Phase III, Open Label, Multicenter, Two-Arm Study Comparing the Efficacy of MEK162 versus Decarbazine in Patients with Advanced Unresectable or Metastatic NRAS Mutation-Positive Melanoma
Kevin Winthrop IRB00009463 The Oregon nontuberculous mycobacteria (NTM) cohort; immune correlates of pulmonary NTM disease progression
Christopher Ryan IRB00009464 A Phase II Study of Sorafenib with Chemotherapy, Radiation, and Surgery for High-Risk Soft Tissue Sarcomas
Matthew Taylor IRB00009480 A Randomized, Double Blind Study to Compare the Complete Remission Rate Following a 5-Week Course of Selumetinib or Placebo and Single Dose Adjuvant Radioactive Iodine Therapy in Patients with Differentiated Thyroid Cancer
Atulya Deodhar IRB00009498 A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects with Non-Radiographic Axial Spondyloarthritis
Brian Druker IRB00009554 A single-arm, multicenter, nilotinib treatment-free remission study in patients with BCR-ABL1 positive Chronic Myelogenous Leukemia in chronic phase who have achieved durable minimal residual disease (MRD) status on first line nilotinib treatment.
Stephen Spurgeon IRB00009556 A Randomized, Double-blind, Placebo-controlled Phase 3 Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor, PCI-32765 (Ibrutinib), in Combination with Bendamustine and Rituximab (BR) in Subjects With Newly Diagnosed Mantle Cell Lymphoma
Dennis Crawford IRB00009557 A Stratified, Post-Market Study of DeNovo NT for Treatment of Femoral and Patellar Articular Cartilage Lesions of the Knee
Richard Maziarz IRB00009571 A Phase II, Randomized Trial of Standard of Care with or without Midostaurin to Prevent Relapse Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients with FLT3-ITD Mutated Acute Myeloid Leukemia
Richard Maziarz IRB00009585 Prospective Multi-Center Cohort for the Evaluation of Biomarkers Predicting Risk of Complications and Mortality Following Allogeneic HCT
Stephen Heitner IRB00009594 Cardiovascular Inflammation Reduction Trial (CIRT)
Fay Horak IRB00009616 Balance Deficits in Multiple Sclerosis and Cerebellar Dysfunction
Erin Gilbert IRB00009694 The Use of Dynamic Contrast Enhanced Magnetic Resonance Imaging (DCE MRI) in the Management of Pancreatic Cancer
Lynn Jansen IRB00009697 Understanding parental (and adolescent) risk/benefit assessments in research
John Morrison IRB00009729 Longitudinal observational study using functional and structural optical coherence tomography to diagnose and guide treatment of glaucoma
Michael Heinrich IRB00009741 A phase II randomized, multicenter study of treatment-free remission in chronic myeloid leukemia in chronic phase (CML-CP) Patients who achieve and sustain MR4.5 after switching to nilotinib
Garet Lahvis IRB00009747 Oregon Animation Test for Social Reciprocity (OATS)
Emma Scott IRB00009761 A Phase 3, Randomized, Double-Blind, Multicenter Study Comparing Oral MLN9708 Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma.
Peter Jacobs IRB00009763 Efferent Suppression of Speech-Evoked OAEs: Implications in Aural Rehab
Penelope Hogarth IRB00009793 Fox Investigation for New Discovery of Biomarkers (BioFIND)
Michael Shapiro IRB00009813 International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA)
Amira Al-Uzri IRB00009828 Designing a Convenient and Precise Device for Home Dried Blood Spot Collection
Lynne Shinto IRB00009880 Omega 3 PUFA for the vascular component of age-related cognitive decline
Akram Khan IRB00009885 Safety and Efficacy of A Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis IM136003
Julie Graff IRB00009892 PVAMC / OHSU J: A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 With Androgen Deprivation Therapy + Bicalutamide in Patients with Newly Diagnosed Metastatic Hormone Sensitive Prostate Cancer
Rachel Cook IRB00009893 S1203: A Randomized Phase III Study of Standard Cytarabine plus Daunorubicin (7+3) Therapy or Idarubicin with High Dose Cytarabine (IA) versus IA with Vorinostat (IA+V) in Younger Patients with Previously Untreated Acute Myeloid Leukemia (AML)
William Gregory IRB00009924 Real-time Observation of Safety and Effectiveness in the Treatment of Female Stress Urinary Incontinence
Kathleen Kemmer IRB00009925 Phase 2 Study to Evaluate the Pharmacokinetics and Drug-Drug Interaction of Cetuximab and Carboplatin in Patients with Recurrent or Metastatic Carcinoma of the Head and Neck
Emma Scott IRB00009936 A Multicenter, Randomized, Open-Label, Phase 2 Study of Carfilzomib With or Without ARRY-520 in Patients with Advanced Multiple Myeloma
Fay Horak IRB00009937 PVAMC / OHSU J: The Effect of Levodopa on Postural Motor Learning in Parkinson Disease
Jeffrey Jensen IRB00010023 A phase IIb randomized, double blind, comparative study to assess the efficacy, safety, tolerability and inhibition of ovulation of two continuous regimens of oral daily 5 mg or 10 mg of ulipristal acetate (UPA), versus a dose of 5.0mg UPA for 24/4 days
Jeremy Cetnar IRB00010028 Phase 2 Study of VS-6063, a Focal Adhesion Kinase (FAK) Inhibitor, in Patients with KRAS Mutant Non-Small Cell Lung Cancer
Deniz Erten-Lyons IRB00010037 Randomised, double-blind, parallel-group, placebo-controlled, fixed-dose study of Lu AE58054 in patients with mild-moderate Alzheimer’s disease treated with donepezil; study 1
Steven Shea IRB00010101 Circadian rhythms and cardiovascular risk
Richard Maziarz IRB00010146 A Multi-Center Biologic Assignment Trial Comparing Reduced Intensity Allogeneic Hematopoietic Cell Transplant to Hypomethylating Therapy or Best Supportive Care in Patients Aged 50-75 with Intermediate-2 and High Risk Myelodysplastic Syndrome
Saurabh Gupta IRB00010161 Randomized, Double-Blind, Placebo-Controlled Phase I/II Study of the Safety and Efficacy of Intracoronary Delivery of Allogeneic Cardiosphere-Derived Cells in Patients With an Anterior Myocardial Infarction and Ischemic Left Ventricular Dysfunction (ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration, ALLSTAR)
Paul Spellman IRB00010163 Reconstructing the Tumor Genome in Peripheral Blood
Kevin Winthrop IRB00010178 The Safety and Effectiveness of the VaricElla zosteR VaccinE (VERVE) in Anti-TNF Users Trial
Donna Graville IRB00010199 The effect of age and bolus consistency on the swallowing efficiency of adults with and without dysphagia
William Messer IRB00010212 Identifying the Determinants of Long-Term Type Specific Immunity in a Dengue Immune Cohort
Katharine Simmons IRB00010228 Tamoxifen for the treatment of unfavorable bleeding patterns in Etonogestrel contraceptive implant users
Joshi Alumkal IRB00010241 Molecular Mechanisms Underlying Tumor Progression Despite Enzalutamide Treatment
Christopher Amling IRB00010252 An Open Registry to Measure the Impact of Adding Genomic Testing (Prolaris®) on the Treatment Decision Following Biopsy in Newly Diagnosed Prostate Cancer Patients by Specialists
Neha Garg IRB00010253 PROMIS in Rheumatology
Kim-Hien Dao IRB00010262 Prospective Evaluation of ruxolitinib Efficacy for CNL/aCML Patients with Mutation of CSF3R
Deniz Erten-Lyons IRB00010264 Protocol H8A-MC-LZAZ(a)/ADC-040-A4 Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease (A4 Study)
Benjamin Ehst IRB00010330 A Trial to Determine the Effect of Psoriasis Treatment on Cardiometabolic Disease
Xin Li IRB00010345 Contrast Enhanced MRI of the Prostate
Michael Shapiro IRB00010361 CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia (CASCADE FH Registry)
Stephen Heitner IRB00010369 A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ISIS 420915 in Patients with Familial Amyloid Polyneuropathy (ISIS 420915-CS2 FAP)
Laura Carim Todd IRB00010373 Behavioral Interventions to Target Self-Control
Akram Khan IRB00010386 A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study to Assess the Efficacy and Safety of Oral BPS 314d-MR Added-On to Treprostinil, Inhaled (Tyvaso®) in Subjects with Pulmonary Arterial Hypertension
Charles Henrikson IRB00010425 A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients with Heart Failure (GENETIC-AF)
Kevin Winthrop IRB00010433 A pilot study for the Varicella Zoster Vaccine (VERVE) Trial
Tomasz Beer IRB00010479 A Randomized, Double Blind, Multicenter, Parallel-group, Phase III Study to Evaluate Efficacy and Safety of DCVAC/PCa Versus Placebo in Men with Metastatic Castration Resistant Prostate Cancer Eligible for 1st Line Chemotherapy
Kathleen Kemmer IRB00010502 A Randomized Placebo-Controlled Phase III Study of Duloxetine for Treatment of Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Women with Early Stage Breast Cancer
Frederick Tibayan IRB00010527 A Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Preoperative Antithrombin Supplementation in Patients Undergoing High-Risk Cardiac Surgery with Cardiopulmonary Bypass (GTI-1307)
Lara Davis IRB00010529 SARC024: A blanket protocol to study oral regorafenib in patients with refractory liposarcoma, osteogenic sarcoma, and Ewing/Ewing–like sarcomas
Steven Bailey IRB00010535 Optical coherence tomography angiography in neovascular age-related macular degeneration
Michael Heinrich IRB00010537 A Phase I, Multicenter, Open-Label Study of Oral ABL001 in Patients with Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Charles Henrikson IRB00010538 Late Sodium Current Blockade in High-Risk ICD Patients - Ranolazine ICD Trial (RAID)
Charles Lopez IRB00010540 A Phase III, Multicenter, Open-Label, Randomized Study of nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone as Adjuvant Therapy in Subjects with Surgically Resected Pancreatic Adenocarcinoma
Kimberly Mauer IRB00010548 Functional Imaging of Light-Induced Activation of Pain-Related Circuitry in Fibromyalgia as a Marker for Central Sensitization
Sancy Leachman IRB00010561 War on Melanoma: Enlisting a cohort of melanoma survivors and their families
Lynne Shinto IRB00010569 Lipoic Acid and Omega-3 Fatty Acids for Cognitive Impairment in Multiple Sclerosis
Cailin Sibley IRB00010580 Risk for Development of ANCA in First-Degree Relatives of Patients with ANCA-Associated Vasculitis
Julie Graff IRB00010586 PVAMC/OHSU J: A three arm randomized, open-label Phase II study of radium-223 dichloride 50 kBq/kg versus 80 kBq/kg, and versus 50 kBq/kg in an extended dosing schedule in subjects with castration-resistant prostate cancer metastatic to the bone
Rebecca Spain IRB00010599 Aerobic exercise to improve brain metabolism in MS
Kathleen Wilder IRB00010604 A randomized, parallel-group, double-blind, placebo-controlled, multi-center study to assess the efficacy and safety of different doses of BAY 1002670 in subjects with uterine fibroids over 3 months
Matthew Taylor IRB00010605 A Phase I, Open-Label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumour Activity of Ascending Doses of AZD5363 under Adaptable Dosing Schedules in Patients with Advanced Solid Malignancies
Anh Nguyen-Huynh IRB00010612 Efficacy and Safety of AM-101 in the Treatment of Acute Peripheral Tinnitus 2 (TACTT2)
Peter Andersen IRB00010613 Phase II Randomized Trial of Transoral Surgical Resection followed by Low-dose or Standard-dose IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer
Matthew Taylor IRB00010630 CLGX818X2109: The LOGIC 2 trial, A phase II, multi-center, open-label study of sequential LGX818/MEK162 combination followed by a rational combination with targeted agents after progression, to overcome resistance in adult patients with locally advanced or metastatic BRAF V600 melanoma
David Sibell IRB00010642 A Randomized Controlled Study to Evaluate the Safety and Effectiveness of the Precision Spinal Cord Stimulator System Adapted for High-Rate Spinal Cord Stimulation
Stephen Heitner IRB00010645 A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of GS-6615 on Exercise Capacity in Subjects with Symptomatic Hypertrophic Cardiomyopathy (GS-US-361-1157)
Christopher Ryan IRB00010659 A Multicenter, Randomized, Open-Label Phase 3 Study to Investigate the Efficacy and Safety of Aldoxorubicin Compared to Investigator’s Choice in Subjects with Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcomas Who Either Relapsed or Were Refractory to Prior Non-Adjuvant Chemotherapy
Elie Traer IRB00010674 A Phase 3 Open-Label Randomized Study of Quizartinib (AC220) Monotherapy Versus Salvage Chemotherapy in Subjects with FLT3-ITD Positive Acute Myeloid Leukemia (AML) Refractory to or Relapsed after First-Line Treatment With or Without Hematopoietic Stem Cell Transplantation (HSCT) Consolidation
Stephen Heitner IRB00010707 Novel Predictors of Outcome in Hypertrophic Cardiomyopathy (HCMR)
Mary Samuels IRB00010709 OCTRI Research Volunteer Registry
Stephen Heitner IRB00010728 A Multicenter, International, Phase 3, Double-Blind, Placebo-Controlled, Randomized Study to Evaluate the Efficacy, Safety, and Tolerability of Daily Oral Dosing of Tafamidis Meglumine (PF-06291826) 20 mg or 80 mg in Comparison to Placebo in Subjects Diagnosed With Transthyretin Cardiomyopathy (TTR-CM) - B3461028 - ATTR-ACT
John Nutt IRB00010745 Effects of augmenting cholinergic function on gait and balance
Andrew Riley IRB00010750 Parent and Provider Perceptions of Behavioral Video Tutorials in Pediatric Primary Care
Charles Lopez IRB00010768 A Randomized, Double-Blind, Phase 3 Study of the JAK 1/2 Inhibitor, Ruxolitinib or Placebo in Combination with Capecitabine in Subjects with Advanced or Metastatic Adenocarcinoma of the Pancreas Who Have Failed or Are Intolerant to First-Line Chemotherapy
Patricia Carlson-Kuhta IRB00010775 Monitoring Balance and Gait Disorders in Parkinson’s Disease with the Home Objective Mobilty Exam (HOME)
Akram Khan IRB00010780 A Treatment Protocol to Allow Patients in the US with Idiopathic pulmonary Fibrosis Access to Pirfenidone
Lissi Hansen IRB00010828 Mother-Daughter Care Dyad Relationships in the Context of Hospice at Home
Kim-Hien Dao IRB00010849 A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Azacitidine with or without Birinapant with a Single Arm Open-Label Run-In Phase in Subjects with Higher Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
Eric Anderson IRB00010866 Safety and Efficacy of nab®-paclitaxel (Abraxane®) in Combination with Carboplatin as First Line Treatment in Elderly Subjects with Advanced Non-Small Cell Lung Cancer (NSCLC): A Phase IV, Randomized, Open-Label, Multicenter Study
Jill Dolata IRB00010870 Early Autism Screening Using the Ages and Stages Questionnaires: Social Emotional-2
Jack Kron IRB00010871 A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Dose Ranging, Parallel Group Study to Evaluate the Effect of GS-6615 on Ventricular Arrhythmia in Subjects with Implantable Cardioverter-Defibrillator (ICD) or Cardiac Resynchronization Therapy-Defibrillator (CRT-D) - GS-US-356-0101 (TEMPO)
Michael Heinrich IRB00010886 A companion sample collection protocol to support the discovery of the mechanisms of resistance to targeted cancer therapies.
Helane Wahbeh IRB00010939 Internet Mindfulness Meditation Intervention (IMMI)
Richard Maziarz IRB00010941 A Multi-center Phase II Trial Randomizing Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls
Cong-Qiu Chu IRB00010947 A Multicenter, Randomized, Double-blind, Parallel Group Study of CNTO 136 (sirukumab) Administered Subcutaneously as Monotherapy Compared With Adalimumab Monotherapy, in Subjects with Active Rheumatoid Arthritis (Protocol CNTO136ARA3005)
Thomas Hwang IRB00010949 Functional Optical Coherence Tomography-Derived Biomarkers for Diabetic Retinopathy
Kerri Winters IRB00010951 Development and feasibility of a remote sensing system to capture symptoms and functional consequences of peripheral neuropathies in cancer patients
John Hunter IRB00010973 Laparoscopic Nissen Fundoplication (LNF) Surgery Versus Transoral Incisionless Fundoplication (TIF): Anti- Reflux Treatment Registry (STAR registry)
William Gregory IRB00010976 Pilot study of Neuropathy and Pelvic Organ Prolapse: Maximizing Imaging Quality
Matthew Taylor IRB00010987 E7080-G000-398: An Open-Label, Randomized, Multicenter, Expanded Access Program With Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer
Rodney Pommier IRB00010991 E2212: A Randomized, Double-Blinded, Placebo-Controlled Phase II Study of Adjuvant Everolimus Following the Resection of Metastatic Pancreatic Neuroendocrine Tumors to the Liver
William Gregory IRB00011008 NGAL biomarker and Urinary Tract Infections: a case control prospective study (NUTI Study)
Joseph Quinn IRB00011013 Investigation of skin lipid biomarkers for Alzheimer’s and Parkinson’s disease progression
Jeffrey Jensen IRB00011016 A single-arm, open-label, multicenter Phase 3 study of the contraceptive efficacy, safety and tolerability of the AG200-15 transdermal contraceptive delivery system (TCDS)
Julie Graff IRB00011025 PVAMC / OHSU J: Addition of Pembrolizumab Upon Progression on Enzalutamide in men with mCRPC
Jeremy Cetnar IRB00011046 S1400, Phase II/III Biomarker-Driven Master Protocol for Second Line Therapy of Squamous Cell Lung Cancer
Angela Senders IRB00011049 Mindfulness-based Stress Reduction for Multiple Sclerosis
Jessica Castle IRB00011092 A randomized, three-way, cross-over study to assess the efficacy of a bi-hormonal closed-loop system with vs without exercise announcement vs open-loop therapy in reducing exercise-related hypoglycemia
Emma Scott IRB00011120 A Phase I Open Label Dose Escalation and Randomized Cohort Expansion Study of the Safety and Tolerability of Elotuzumab (BMS-901608) Administered in Combination with either Lirilumab (BMS-986015) or Urelumab (BMS-663513) in Subjects with Multiple Myeloma
Daniel Herzig IRB00011161 A Phase II Multicenter Randomized Trial Evaluating 3-Year Disease-Free Survival in Patients with Locally Advanced Rectal Cancer Treated with Chemoradiation Plus Induction or Consolidation Chemotherapy, and Total Mesorectal Excision or Non-Operative Management
Nicole Marshall IRB00011175 Maternal Body Composition Regulates Placental Function and Fetal Growth
Kelvin MacDonald IRB00011230 A Two-Part Multicenter Prospective Longitudinal Study of CFTR-Dependent Disease Profiling in Cystic Fibrosis (PROSPECT)
Donna Graville IRB00011259 Voice Use and Vocal Effort in Older Adults
Gina Vaccaro IRB00011274 Randomized Phase II Trial of Single Agent MEK Inhibitor Trametinib (GSK1120212) Vs 5-Fluorouracil or Capecitabine in Refractory Advanced Biliary Cancer
Andrew Ahmann IRB00011300 A Randomized Trial Comparing Continuous Glucose 16 Monitoring With and Without Routine Blood Glucose 17 Monitoring in Adults with Type 1 Diabetes
Eva Medvedova IRB00011350 Phase 3 Study Comparing Daratumumab, Bortezomib and Dexamethasone (DVd) vs Bortezomib and Dexamethasone (Vd) in Subjects With Relapsed or Refractory Multiple Myeloma
Allison Lindauer IRB00011476 Alzheimer's Care via Telemedicine for Oregon (ACT-ON), Phase I
For more information:
Call: 503-494-1080

You may qualify for additional trials within our Phase 1 Program